StoxGud Sign in
30

Biofil Chemicals & Pharmaceuticals Limited

NSE: BIOFILCHEM · Unclassified

₹30.77+1.79%06 Nov 2026
Check figures: unusual quarterly results in JUN '25 (₹2.41 cr vs a typical ₹0.17 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about Biofil Chemicals & Pharmaceuticals Limited — computed from its filings, no language model
Market cap₹50 cr
Current price₹30.77
High / Low₹46 / ₹26
P/E104.3
P/B2.32
Book value₹13.2
ROE2.2%
ROCE3.3%
Debt / equity0.14
Dividend yield—
EPS (TTM)₹0.29
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
showing latest 6 of 18 periods
FY09†FY10†FY11†FY12†FY13†FY14†FY15†FY16†FY17†FY18†FY19FY20FY21FY22FY23FY24FY25FY26
Revenue1.41.82.86.36.07.25.913.413.512.323.129.735.822.430.040.033.428.4
EBITDA-0.2-0.6-0.50.41.01.50.81.12.60.91.01.81.61.31.20.80.80.7
Operating margin-13.6%-33.0%-18.1%7.0%16.8%21.3%13.7%8.0%19.7%7.5%4.4%6.1%4.5%5.9%3.9%2.0%2.5%2.3%
Interest———0.10.20.20.20.20.20.20.20.10.10.00.00.00.00.0
Depreciation—0.10.20.20.20.20.30.30.30.30.40.40.40.40.40.40.40.3
Profit before tax-0.20.51.00.10.71.20.81.02.30.60.61.51.91.00.80.90.73.5
Tax0.00.00.00.00.00.10.10.20.50.10.10.30.70.30.20.20.20.7
Net profit-0.20.51.00.10.71.10.70.81.80.50.51.21.20.70.60.70.62.8
EPS ₹——————————0.300.760.760.440.290.440.341.71
Operating cash flow—————————————-0.2-0.12.4-1.9-0.6
Capex—————————————0.10.00.00.10.2
Dividend paid—————————————0.00.00.00.00.0
Total assets——————————————31.447.151.042.9
Equity——————————————17.318.218.821.6

Quarterly performance

last 76 quarters · ₹ crore
showing latest 8 of 76 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†MAR '12†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†JUN '18SEP '18DEC '18MAR '19JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
Revenue0.10.30.40.30.20.30.60.21.40.10.00.10.81.10.80.70.30.44.91.20.70.83.30.90.93.12.30.50.70.93.80.70.66.95.20.32.94.06.37.10.80.93.54.22.114.32.51.611.612.83.72.316.03.214.25.413.71.61.612.32.61.513.62.417.45.015.28.42.414.28.36.413.50.97.612.3
Operating profit0.00.1-0.30.00.00.1-0.30.00.3-0.1-0.8-0.00.10.1-0.60.10.10.10.10.10.10.10.70.10.10.50.80.00.20.20.40.2-0.00.20.70.10.30.61.60.20.20.30.30.20.20.40.30.20.90.30.5-0.30.90.60.40.30.40.50.10.40.10.20.40.40.20.2-0.00.30.10.30.10.00.10.10.40.1
Operating margin14.3%34.5%-81.6%10.3%17.6%16.1%-47.6%14.3%18.6%-111.1%-7800.0%-66.7%11.2%4.5%-76.9%12.2%48.3%21.6%2.6%9.0%12.7%12.7%21.5%14.8%12.1%15.7%35.4%-0.0%33.3%23.0%9.5%23.2%-1.8%2.6%14.2%39.4%11.6%15.1%25.2%2.8%20.5%33.0%7.3%3.8%9.3%2.7%11.3%13.8%7.6%2.0%14.0%-12.6%5.7%19.1%2.6%6.1%2.7%30.1%8.5%3.1%5.7%15.4%3.0%17.3%1.4%3.8%-0.2%3.7%5.0%2.2%1.3%0.2%0.8%10.5%5.7%1.1%
Other income——0.0——0.1————1.4———1.7————0.00.00.00.00.00.00.00.00.1—0.10.2—0.20.00.1—0.0—0.10.00.00.00.10.00.00.00.00.00.00.10.00.60.10.00.00.00.00.10.00.00.00.00.00.00.00.00.40.00.00.00.22.80.10.10.10.1
Interest0.10.10.10.0——0.0———0.0———0.00.00.00.00.00.00.00.00.10.00.00.00.00.00.00.10.00.00.00.00.00.00.00.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0-0.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Depreciation0.0———0.00.00.00.00.00.00.00.00.00.00.10.00.00.00.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1
Profit before tax-0.10.0-0.50.00.00.1-0.30.00.1-0.10.6-0.10.10.01.00.00.10.00.00.10.00.00.60.10.00.40.70.10.10.10.50.10.10.10.70.00.30.51.50.10.10.20.20.10.10.30.10.10.80.20.40.20.90.50.30.20.30.40.00.30.10.10.30.30.10.10.30.20.00.20.22.80.10.10.50.1
Tax0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.00.00.00.10.00.00.00.20.00.00.00.50.00.00.00.10.00.00.00.10.00.00.00.30.00.00.00.70.10.10.10.10.10.00.00.10.10.00.00.00.10.00.10.10.30.00.00.30.0
Net profit-0.10.0-0.50.00.00.1-0.30.00.1-0.10.6-0.10.10.01.00.00.10.00.00.10.00.00.60.10.00.40.60.10.10.10.40.10.10.10.50.00.30.51.00.10.10.20.10.00.00.30.00.10.80.20.10.20.90.5-0.40.20.20.3-0.00.20.10.10.20.20.10.10.20.20.00.20.22.40.10.10.20.1
EPS ₹—0.00-0.050.000.000.01-0.03—0.01-0.010.06-0.010.010.000.060.000.000.000.000.000.000.000.340.000.000.030.360.000.010.010.230.030.050.070.320.020.170.300.620.060.040.140.050.040.060.180.010.070.490.140.110.130.570.31-0.250.110.130.210.010.130.030.060.070.150.080.060.150.100.010.100.121.480.050.050.130.07
Revenue YoY————142.9%6.9%65.8%-27.6%752.9%-71.0%-98.4%-71.4%-44.8%1144.4%7700.0%1133.3%-63.7%-67.0%530.8%64.9%144.8%113.5%-32.9%-27.9%28.2%294.9%-31.5%-43.2%-20.9%-72.1%66.8%38.0%-20.8%692.0%38.5%-52.2%412.3%-42.4%19.9%2039.4%-71.6%-77.1%-43.3%-40.2%157.8%1470.3%-30.4%-62.3%443.5%-10.8%50.6%44.7%37.7%-75.0%282.8%133.5%-14.2%-48.9%-88.4%129.2%-80.9%-8.6%725.5%-80.3%563.0%237.6%11.6%247.3%-86.1%182.3%-45.1%-23.8%461.8%-93.9%-9.3%92.1%
Profit YoY—————400.0%——700.0%-186.7%——-25.0%—64.4%—16.7%0.0%-99.0%66.7%-57.1%0.0%5400.0%0.0%0.0%1266.7%7.3%0.0%400.0%-80.5%-37.3%0.0%-40.0%50.0%40.5%-40.0%200.0%308.3%92.3%233.3%-74.1%-55.1%-92.0%-100.0%-100.0%31.8%-75.0%——-20.7%650.0%100.0%17.7%121.7%-373.3%-22.7%-77.4%-33.3%—23.5%-76.2%-70.6%—14.3%140.0%-10.0%19.0%-29.2%-83.3%77.8%-20.0%1317.6%300.0%-50.0%5.0%-95.4%

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 73 periods
JUN '08SEP '08DEC '08MAR '09JUN '09SEP '09DEC '09MAR '10JUN '10SEP '10DEC '10MAR '11JUN '11SEP '11DEC '11MAR '12JUN '12SEP '12DEC '12MAR '13JUN '13SEP '13DEC '13MAR '14JUN '14SEP '14DEC '14MAR '15JUN '15SEP '15DEC '15MAR '16JUN '16SEP '16DEC '16MAR '17JUN '17SEP '17DEC '17MAR '18JUN '18SEP '18DEC '18MAR '19JUN '19SEP '19DEC '19MAR '20JUN '20SEP '20DEC '20MAR '21JUN '21SEP '21DEC '21MAR '22JUN '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
ROE—————————————————————————————————————————————————————————3.3%1.9%3.3%3.5%3.8%3.7%3.8%3.5%2.9%3.3%2.9%14.9%13.4%13.0%12.9%2.2%
ROCE—————————————————————————————————————————————————————————4.9%3.1%4.7%4.9%5.3%5.1%4.8%4.3%3.6%4.2%4.0%17.1%15.8%15.2%14.1%3.3%
Net margin-51.5%-39.8%-28.7%-12.9%-13.6%-4.2%-16.4%30.7%29.2%46.9%30.7%35.9%31.7%37.5%50.5%2.2%2.4%1.7%1.6%11.0%11.6%11.2%12.7%15.1%15.9%18.2%20.0%11.1%10.7%10.0%5.3%5.8%5.8%6.1%10.5%13.3%9.2%9.2%9.2%3.8%3.9%2.8%1.5%1.3%2.0%4.0%4.0%4.3%4.6%4.4%7.2%3.5%3.1%1.3%0.9%3.1%2.5%3.1%1.8%1.9%3.0%1.9%1.7%1.7%1.4%1.7%1.5%1.6%8.9%6.7%9.5%9.8%1.4%
EBITDA margin-16.5%-13.3%-17.4%-13.6%-14.4%1.9%-4.2%-33.0%-40.4%-86.5%-34.2%-18.1%-10.8%-10.9%-13.3%7.0%6.8%5.7%5.6%16.8%18.1%17.9%17.5%21.3%20.6%23.2%28.5%13.7%15.9%12.0%5.8%8.0%8.0%9.0%14.5%19.7%13.5%14.1%14.9%7.5%9.4%8.5%4.2%4.5%5.3%5.9%5.8%6.3%4.5%4.0%6.9%4.5%5.7%4.6%4.5%5.9%4.7%6.4%5.0%3.9%6.0%3.7%3.3%2.0%1.5%1.9%1.8%2.5%1.8%1.3%1.1%2.3%2.2%
Debt / equity—————————————————————————————————————————————————————————0.030.030.030.030.030.030.020.020.030.030.030.030.000.000.140.14
Interest coverage-1.41—————————————19.332.872.892.622.304.474.143.875.338.508.509.255.714.764.764.485.817.066.948.0610.3814.4714.8813.7112.124.694.444.625.064.695.009.8710.0712.7715.9118.8026.75-47.00-37.80-20.67-19.5026.2527.2521.5013.7520.7521.7524.0031.0022.2520.0017.0016.0019.2582.50112.33162.50346.00—
Asset turnover—————————————————————————————————————————————————————————0.550.550.960.640.830.910.850.980.740.960.660.620.770.530.660.80

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 8 periods
SEP '22MAR '23SEP '23MAR '24SEP '24MAR '25SEP '25MAR '26
Share capital16.316.316.316.316.316.316.316.3
Other equity / reserves0.81.01.41.92.12.55.05.3
Total equity17.117.317.718.218.418.821.321.6
Borrowings0.50.50.60.40.50.50.03.0
Current liabilities15.613.724.228.523.331.933.720.7
Non-current liabilities0.40.40.40.40.40.30.30.6
Total assets33.131.442.247.142.051.055.442.9
Property, plant & equipment9.29.08.88.68.48.37.06.9
Investments0.00.00.00.00.00.00.00.0
Inventories0.91.25.12.56.83.33.54.0
Receivables22.320.527.433.025.538.340.827.6
Cash & equivalents0.10.00.00.10.20.10.20.1

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY25FY26
Cash from operations-0.2-0.12.4-1.9-0.6
Cash from investing-0.1-0.0-0.0-0.11.1
Cash from financing-0.00.0-0.10.02.5
Capex0.10.00.00.10.2
Free cash flow-0.3-0.12.4-2.0-0.8
Dividends paid0.00.00.00.00.0

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹6.9 cr16%
Inventories
₹4.0 cr9%
Receivables
₹27.6 cr64%
Cash & equivalents
₹0.1 cr0%
Other assets
₹4.3 cr10%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Biofil Chemicals & Pharmaceuticals Limited5030.77104.32.322.2%

StoxGud checklist: Bearish setup · 3/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+1.1%
6 months-11.1%
1 year-20.7%
3Y CAGR-14.5%
5Y CAGR-13.0%
10Y CAGR—
50-day avg₹31.11
200-day avg₹32.63
RSI (14)54

FAQs

What is the share price of Biofil Chemicals & Pharmaceuticals Limited?

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) closed at ₹30.77 on NSE on 06 Nov 2026.

What is the market cap of Biofil Chemicals & Pharmaceuticals Limited?

₹50 crore at the latest close.

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals Limited?

104.3, on trailing-twelve-month earnings from its filings.

How fast is Biofil Chemicals & Pharmaceuticals Limited growing?

Biofil Chemicals & Pharmaceuticals Limited: revenue has compounded at -1.9% a year over three years; net profit at 70.8% a year. Latest-quarter revenue is up 92.1% year on year, profit down 95.4%.

How profitable is Biofil Chemicals & Pharmaceuticals Limited?

On a trailing-twelve-month basis return on equity is 2.2%, return on capital employed 3.3%, operating margin 2.2%, net margin 1.4%.

How much debt does Biofil Chemicals & Pharmaceuticals Limited have?

Biofil Chemicals & Pharmaceuticals Limited is lightly geared: debt to equity is 0.14 with borrowings of ₹3 cr against cash of ₹0 cr (balance sheet of 2026-03-31).

Financials parsed from Biofil Chemicals & Pharmaceuticals Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '07, annual from FY09, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before JUN '18 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.